Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A reAl-World Evidence Study Using Alberta Population Based Data to Describe Treatment Patterns for Metastatic castRation sENsitivE proState Cancer patientS (AWARENESS)

NCT05149131 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05149131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05149131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A reAl-World Evidence Study Using Alberta Population Based Data to Describe Treatment Patterns for Metastatic castRation sENsitivE proState Cancer patientS (AWARENESS)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 17, 2022
Completion date
August 16, 2022
Enrollment
960 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-sensitive prostate cancer